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Summary
Measuring differential methylation of the DNA is the nowadays most common approach
to linking epigenetic modifications to diseases (called epigenome-wide association studies,
EWAS). For its low cost, its efficiency and easy handling, the Illumina HumanMethyla-
tion450 BeadChip and its successor, the Infinium MethylationEPIC BeadChip, is the by
far most popular techniques for conduction EWAS in large patient cohorts. Despite the
popularity of this chip technology, raw data processing and statistical analysis of the ar-
ray data remains far from trivial and still lacks dedicated software libraries enabling high
quality and statistically sound downstream analyses.
As of yet, only R-based solutions are freely available for low-level processing of the Il-
lumina chip data. However, the lack of alternative libraries poses a hurdle for the de-
velopment of new bioinformatic tools, in particular when it comes to web services or
applications where run time and memory consumption matter, or EWAS data analysis
is an integrative part of a bigger framework or data analysis pipeline. We have there-
fore developed and implemented Jllumina, an open-source Java library for raw data ma-
nipulation of Illumina Infinium HumanMethylation450 and Infinium MethylationEPIC
BeadChip data, supporting the developer with Java functions covering reading and pre-
processing the raw data, down to statistical assessment, permutation tests, and identifica-
tion of differentially methylated loci. Jllumina is fully parallelizable and publicly available
at http://dimmer.compbio.sdu.dk/download.html
*To whom correspondence should be addressed. Email: roettger@imada.sdu.dk
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1 Introduction
DNA methylation is an epigenetic process associated to genomic imprinting, inactivation of the
X chromosome in females, and cellular specialization [1]. DNA methylation patterns are sub-
ject to naturally occurring changes due to aging but are also influenced by the development of
diseases such as cancer and diabetes [2]. Differentially methylated DNA loci can be identified
by using DNA bisulftite treatment and quantified by microarray technologies such as the Illu-
mina Infinium HumanMethylation450 and Infinium MethylationEPIC BeadChip, which cover
around 450,000 and 850,000 CpG sites respectively along the human genome [3, 4]. Even
though this is only a very small fraction of all (estimated 20 millions) CpG sites in the human
genome, the Illumina probes are designed to assess CpG positions of 99% of the RefSeq se-
quences. 72% of these CpG positions are distributed in promoter regions and gene body, the
remaining in intergenic and 3’UTR regions [3, 4].
Due to the popularity and importance of the Illumina arrays it is crucial that the practitioners
are equipped with easy-to-use, interactive and integrated software solutions, which aid with all
necessary data analysis steps from raw data processing to the identification of significantly loci
differentially methylated between two or more groups of patients, or correlated with clinical
outcome parameters. Software developers, so far, face a set of central issues when working
with Illumina array data: The raw data is only provided in an undocumented proprietary binary
file format (IDAT). Accessing the data requires the usage of Illumina’s closed-source GenomeS-
tudio software in order to manually convert the IDAT file into a human-readable and parsable
ASCII file [1]. Recently, essential parts of the file format have been re-engineered in the frame-
work of the open source R-package Illuminaio [1], which now provides simple I/O operation
functionality in R.
The advent of Illuminaio has lead to the development of several of sophisticated software pack-
ages for EWAS data analysis, such as Minfi [5], RNBeads [6] and WaterMelon [7]. As these
packages are based on Illuminaio, they are implemented in R, which poses some limitations
when considering the usability for non-computer experts. Even for experienced software de-
velopers, R may render problems: R versions and package incompatibilities, overhead when
binding with libraries, lack of software design patters, performance and integration in non-R
based frameworks, just to name a few.
In order to provide the community with a wider basis for future software implementations, we
have developed Jllumina, a Java library for the handling and processing of Illumina raw data
files. It is the backbone of the recently published DiMmer tool [8]. Besides the very I/O capa-
bility, we have additionally implemented popular post-processing functions like quality control,
normalization, cell composition correction, and significance level calculations. The provided
features are mostly parallelizable re-implementations based on the R packages Illuminaio [1]
and Minfi [5]. The library can process both, Illumina Infinium HumanMethylation450 data and
the new Infinium MethylationEPIC BeadChip data.
In the remainder of this manuscript, we first describe the general workflow of an EWAS study,
and the raw data format. Afterwards, we describe the methods provided by Jllumina in de-
tail. The technical documentation can be found online at http://dimmer.compbio.
sdu.dk/javadoc.
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Loading set Cell composition Quantile normalization CpG statistics
Jllumina 14 secs 66 secs 21 secs 89 secs
Minfi 68 secs 194 secs 32 secs 126 secs
Table 1: Jllumina and Minfi R package run times. All steps were performed on a standard Mac-
book Air with Intel core i5, 1.6 Ghz and 8GB of RAM. We used 1000 permutations for Jllumina’s
CpG statistics.
2 Methods
2.1 Overview
EWAS data analysis can be divided in two major parts: pre-processing and downstream anal-
ysis. The first one regards to the manipulation of the methylation signal distribution in or-
der to remove artifacts, which can compromise the downstream analysis. Downstream anal-
ysis, relies on the discovery of differentially methylated positions/regions and its association
to a specific phenotype/disease of interest, and is strongly dependent of the pre-processing
step. Jlummina provides an API for the implementation of any step associated to the pre-
processing of Illumina raw data: (i) Background correction, which is related to the source
of noise intrinsic to the technology; (ii) Probe filtering: The quality of the signal from a
signal probe can be checked using the control probes provided by Illumina. Removing low
quality probes can maximize the correct identification of differentially methylated positions;
(iii) Normalization removes cross-array artifacts, and integrates the distributions from Infinium
I and Infinium II probe types. In addition, Jlummina also provide classes for downstream
analyses: (i) statistical testing of single CpG sites using t-test (case-control), and (ii) lin-
ear regression models (multiple labels), as well as (iii) permutation test functions to retrieve
empirical p-values, and (iv) methods for correcting p-values for multiple testing. A com-
parison table, for the steps mentioned before, with well known R-packages is available at
http://dimmer.compbio.sdu.dk/download.html. In addition, we give run times
for Illumina array data comparing the Minfi R package and Jllumina in Table 1, using the Poly-
cystic ovarian syndrome (PCOS) dataset, consisting of a case-control cohort with 60 Chinese
female patients [9].
2.2 Calculating the Methylation Levels
An IDAT file stores the methylation intensities for a large set of CpG sites of a single sample.
Note that the Illumina Infinium HumanMethylation450 and Infinium MethylationEPIC Bead-
Chip methylation platforms actually employs two different probe types simultaneously in one
experiment: Infinium I (which uses two assays for a given locus to detect the methylated and
unmethylated signal) and Infinium II (which uses only one assay to explore a locus pair but in
different color channels). Each probe, independent of its assay type, results in two different
intensity values, one for the methylated and one for the unmethylated channel.
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The most important information about a CpG site is its methylation level, which is either pro-
vided as the so-called β-value
β-value =
M
U +M
or the Logit transformed M -value
M -value = log2
(
β
1− β
)
where M corresponds to the mean intensity of methylated locus and U to the mean intensity of
the unmethylated locus [10].
2.3 Background Correction
Illumina provides control probes to generate a background signal. The noise associated to the
Illumina signal is (by default) assumed to be 5% of the background signal. Hence, our library
reads the methylation level at 5% of the methylation distribution of the methylation levels of
the control probes, and then subtracts this value from each of the 450,000 (850,000) CpG
methylation signals of the given array.
2.4 Probe Filtering
The background signals from the the control probes are also used to assess the quality of the
CpG sites’ measurements. For a given array, the proportion of control probes in which its
signal is at least as strong as the methylation signal from a given CpG site is called detection-P.
The cumulative probability associated to this proportion is estimated assuming that the signal
follows a standard normal distribution. Now low-quality CpG sites can be filtered by applying
a p-value threshold. A CpG is dropped if the proportion of low-quality CpG sites across all
samples is greater than a second threshold, default: 5%.
2.5 Normalization
Jllumina comes with two types of normalization methods: the Illumina normalization and quan-
tile normalization. Any other normalization function can be developed by extending the Ab-
stractNormalization class (details in Jllumina javadoc).
2.5.1 Illumina Normalization
This method is based on the Illumina software GenomeStudio. Essentially, it uses the mean
methylation values of the control probes to calculate a factor for each sample in order to cor-
rect the signal from intra/inter array artifacts. We provide a full Java re-implementation of this
method adopted from the R-based Minfi package. The function preprocessIllumina is an im-
plementation of the Illumina normalization and background correction. We tested and matched
our library’s output against the Minfi package on some test data sets.
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2.5.2 Quantile Normalization
The (un)methylated signals are obtained by the two different assays (Infinium I and Infinium II).
They differ in the overall methylation signal distribution, which renders a direct comparison im-
possible. With Jllumina, we implemented a classical (non-stratified) quantile normalization and
a subset quantile normalization (stratified), taking into account the Illumina probe annotation of
CpG sites as described by Touleimar & Jo¨rg Tost [11]. The idea of quantile normalization is to
make two different distributions similar. This is achieved iin Jllumina by: (i) computing the row
means of the sorted methylation signal matrix and (ii) replacing the original methylation values
by the computed mean values, according to the assigned ranks. This approach is straightfor-
ward for the non-stratified quantile normalization. The stratified quantile normalization follows
the same two steps described before for Infinium type II probes, but a different approach for
Infinium type I probes: the row means are computed by interpolating a reference distribution
from the normalized values of Infinium type II probes and then the column-wise replacement is
performed. We tested both, the stratified and the non-stratified methods, for correctness against
the distributions computed by Minfi package [5]. On our test data, the results were exactly the
same but achieved much faster due Jllumina’s full parallelization.
2.6 Blood Cell Composition Estimation
One of the major goals in epigenetics is the association of differentially methylated sites to a
phenotype of interest. In this context, the observed methylation signal has to take into account
heterogeneity of cells in a given sample. Since blood samples are often used for methylation
analysis, with Jllumina we provide an implementation for estimating the cell blood population
distribuion for six cell types (NK, CD8T, CD4T, granulocytes and monocytes). This imple-
mentation follows the same strategy as the estimateCellCounts function of the Minfi package.
The cell composition estimation uses a linear regression calibration step, in which the methyla-
tion contribution (coefficients) from the six cell types are computed. Given the surrogate target
methylation values and the computed coefficients the proportion of cells can be estimated by
minimizing a quadratic objective function [12].
2.7 Statistical Significance
The class CpGStatistics was implemented in order to compute p-values, and coefficients given
a beta-value set and a statistical estimator (t-test or linear regression). The t-test is used for
case-control studies and performed for paired (e.g. twin cohorts) or unpaired data sets, and can
assume equal or non-equal variance between the two populations; likewise for linear regression
models.
2.8 Permutation Tests
In order to assess p-value significance the CpGStatistics class also provides a parallelized per-
mutation test function and a set of multiple testing correction functions. Here, we essentially
doi:10.2390/biecoll-jib-2016-294 5
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permute the patient labels and rerun the whole data analysis pipeline to calculate empirical p-
values, the false discovery rate (FDR), the family wise error rate (FWER) and step-down min-p
values. The empirical p-values can be understood as the frequency of permuted p-values at least
as good as the original one. The FDR p-values (Beinjamini-Hochberg) [13] are computed as
the proportion of permuted p-values, from all CpG sites, which are bigger than a given original
p-value of a single CpG site. The FWER p-values (Bonferroni correction) is computed as the
frequency of p-values, from a single CpG, which are at least as good as the smallest p-value
found after running the permutations. Step-down minP [14] is a multiple test correction similar
to the Bonferroni correction but less restrictive. Figure 1 plots the original test p-values against
the corrected ones using the different methods described above using a Illumina Infinium Hu-
manMethylation450 test data set available at http://dimmer.compbio.sdu.dk/download.html.
3 Results & Conclusion
With Jllumina, we present the first Java library providing for processing and manipulating Il-
lumina IDAT files. Besides the capabilities for processing the raw input files, Jllumina also
implements the most popular statistical analyses required for high-quality EWAS studies. Jllu-
mina supports both, Illumina Infinium HumanMethylation450 and Infinium MethylationEPIC
BeadChip data. Thus, Jllumina will enable Java developers to fully integrate standard EWAS
data manipulation and statistics into their Java-based software frameworks. In the future, we
will implement functions for NGS bisulfite data analysis and for integrating EWAS results with
biological networks using Cytoscape and enrichment methods [15, 16, 17]. This will allow
us to run de novo network enrichment to identify subnetworks (rather than DMRs) that are
affected by differential DNA methylation.
4 Availability
Jllumina is open source and publicly available at http://dimmer.compbio.sdu.dk/
download.html. The website also provides API documentation (http://dimmer.compbio.
sdu.dk/javadoc/index.html) and coding examples.
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(a) (b)
(c) (d)
Figure 1: Original p-values plotted against a) empirical p-values, b) FDR-corrected p-values, c)
FWER-corrected p-values, and d) Step-down minP corrected p-values, from the PCOS dataset
using 1000 permutations. Apparently, Bonferoni corretion is too strict. We suggest to use FDR
correction or empirical p-values.
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